NDAINJECTIONINJECTABLE
Approved
Jan 1946
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
Drug data last refreshed 18h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Alcohol 5% and Dextrose 5% is an intravenous injectable solution combining ethanol and glucose for parenteral nutrition and caloric support. This product provides both a carbohydrate energy source (dextrose) and alcohol as a secondary caloric and potentially therapeutic agent. It is administered to patients requiring supplemental nutrition, particularly in hospital or clinical settings.
LOE Approaching
This legacy injectable is approaching loss of exclusivity with moderate competitive pressure (30%), suggesting a contracting brand team focused on defending market share rather than growth initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
This legacy product has zero actively linked job openings, reflecting its mature market position and approaching loss of exclusivity. Career opportunities are limited to defensive operations and cost optimization rather than growth or innovation roles.
Brand ManagerProduct Manager
Worked on ALCOHOL 5% AND DEXTROSE 5% at B. Braun? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.